Filter by Lead Doctor (All Doctors) Jennifer Linehan, M.D.Przemyslaw Twardowski, M.D.Przemyslaw Twardowski, M.D. Title Physician A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer NCT ID : 05483868 Phase : 1 Location : Saint John's Cancer Institute Jennifer Linehan, M.D. Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer (Solar-Recur) NCT ID : 06235151 Phase : 3 Location : Saint John's Cancer Institute Przemyslaw Twardowski, M.D. Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer (Solar-Recur) NCT ID : 06235099 Phase : 3 Location : Saint John's Cancer Institute Przemyslaw Twardowski, M.D. A Study of ARV-766 Given by Mouth in Men With Metastatic Castration-resistant Prostate Cancer Who Have Progressed on Prior Approved Systemic Therapies NCT ID : 05067140 Protocol Number : ARV-766mCRPC-101 Phase : 1/2 Location : Saint John's Cancer Institute Przemyslaw Twardowski, M.D. Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate Cancer NCT ID : 03972657 Protocol Number : R5678-ONC-1879 Phase : 1/2 Location : Saint John's Cancer Institute Przemyslaw Twardowski, M.D. White Button Mushroom Supplement for Biochemically Recurrent Prostate Cancer Following Local Therapy and in Therapy Naïve Patients NCT ID : 04519879 Protocol Number : White Button Mushroom Phase : 2 Location : Santa Monica, CA Przemyslaw Twardowski, M.D.
